BackG1 Therapeutics Overview

G1 Therapeutics Research & Development

Research & Development expenses for GTHX.

Quarterly R&D Expenses

$5.74M
↓ 52.34% YoY

As of Jun 30, 2024

Annual R&D Expenses (TTM)

$29.25M
↓ 54.08% YoY

Trailing 12 months ending Jun 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin